Claims assessment · Nutrition claim
No industrial trans fats in our foods
Typical treatment across five regimes. Every verdict below is tied to a stated legal hook.
Market comparison
How this claim is typically treated
Five major markets · one reviewed comparison
| Market | Typical treatment | Legal basis | What is required |
|---|---|---|---|
| European UnionEU | Conditional | View legal reasoningUCPD; Reg 1924/2006 context; EU trans-fat limit (Reg 2019/649) | Compliant with the 2 g/100 g fat industrial trans-fat limit; portfolio-wide verification. |
| United KingdomUK | Conditional | View legal reasoningCMA Code; retained rules | Portfolio testing. |
| United StatesUS | Conditional | View legal reasoningFTC/FDA rules; PHO ban | Formulation records. |
| CanadaCA | Conditional | View legal reasoningCompetition Act s.74.01(1)(b.1) | Testing evidence. |
| AustraliaAU | Conditional | The cited source is recorded in the assessment. View legal reasoningACL s.18; FSANZ | Formulation data. |